Pig-A Mutation Analysis via Two-Color Flow Cytometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for quantifying in vivo mutation rates in individuals exposed to genotoxicants using the Pig-A gene are inefficient, requiring multiple labeling reagents and complex procedures, and fail to differentiate between mature and immature erythrocytes, leading to contamination and variable baseline mutation frequencies.
Innovation Solution
A method involving two-color flow cytometry using a reagent that binds to GPI-anchor competent cells and a nucleic acid dye to differentiate normochromatic erythrocytes from reticulocytes, allowing for the enumeration of GPI anchor-deficient cells relative to total erythrocytes or reticulocytes, with improved resolution and reduced reagent usage.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If multiple labeling reagents are used to differentiate cell types, then measurement precision is improved, but device complexity and ease of operation deteriorate
Solution Approach 1:
The patent extracts and eliminates the need for anti-CD45 antibody labeling by using an alternative approach: treating blood samples with saponin to create pores in cell membranes, then using propidium iodide staining to differentiate nucleated cells from erythrocytes based on DNA content. This removes the complex multi-reagent approach while maintaining differentiation accuracy.
Solution Approach 2:
The patent makes the propidium iodide stain serve multiple functions: it stains nucleated cells (leukocytes and platelets) to allow their identification and exclusion, while simultaneously enabling the differentiation of reticulocytes from mature erythrocytes based on relative fluorescence intensity. This single reagent replaces multiple specialized labeling reagents.
2Measurement precision
If multiple labeling reagents are used to differentiate cell types, then measurement precision is improved, but ease of operation worsens
Solution Approach 1:
The patent removes the requirement for multiple specialized antibodies and labeling steps. Instead, it uses a simple saponin treatment followed by propidium iodide staining, which can be performed with standard laboratory reagents and equipment, significantly improving ease of operation.
Solution Approach 2:
The patent changes the measurement parameter from detecting specific surface antigens (requiring multiple antibodies) to detecting DNA content and relative fluorescence intensity. This parameter change allows the use of a single fluorescent stain and simplifies the operational procedure while maintaining precise cell type differentiation.
3Adaptability or versatility
If anti-CD45 antibody is used to differentiate leukocytes from erythrocytes, then leukocyte identification is achieved, but resolution and measurement precision deteriorate
Solution Approach 1:
The patent removes the anti-CD45 antibody approach entirely and replaces it with propidium iodide staining. This extraction of the problematic reagent eliminates the resolution issues while maintaining the ability to identify and exclude leukocytes from the analysis.
Solution Approach 2:
Instead of using a specific antibody marker (anti-CD45), the patent uses a general DNA-staining approach (propidium iodide) that copies the functional outcome of leukocyte identification through a different mechanism - detecting nucleated cells based on their DNA content rather than surface antigens.
4Measurement precision
If complex multi-reagent procedures are used, then cell differentiation accuracy is improved, but productivity and analysis time worsen
Solution Approach 1:
The patent merges multiple differentiation functions into a single staining step. Propidium iodide simultaneously identifies nucleated cells (leukocytes and platelets) and differentiates reticulocytes from mature erythrocytes based on relative fluorescence intensity. This consolidation eliminates multiple sequential labeling steps and improves throughput.
Solution Approach 2:
The propidium iodide stain serves universal functions: it stains all nucleated cells for exclusion from erythrocyte analysis, and it enables reticulocyte identification through relative fluorescence intensity measurement. This single reagent replaces multiple specialized stains, significantly improving productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables reliable, high-throughput scoring of Pig-A mutation frequency using fewer reagents, reducing contamination and variability, and is compatible with delayed quantitative analyses, enhancing user-friendliness and logistical flexibility.
Implementation Method 1
contacting the enriched erythrocyte sample with a first reagent that binds GPI anchor-expressing erythrocytes, but not GPI anchor-deficient erythrocytes, and that is conjugated to or can be bound by a first fluorochrome
Implementation Method 2
contacting the enriched erythrocyte sample with a second fluorescent reagent that differentially labels normochromatic erythrocytes from reticulocytes and leukocytes
Implementation Method 3
detecting the fluorescent emission and light scatter produced by erythrocytes labeled with the first fluorochrome
Data Source
AI summary
The invention relates to methods and kits for the quantitative analysis of in vivo mutation frequencies of the Pig-A gene in individuals exposed to a genotoxicant, particularly using peripheral blood samples of vertebrates.